AG2037

A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called glycinamide ribonucleotide formyl transferase inhibitors.

Sustancia en estudio para el tratamiento del cáncer. Es un tipo de inhibidor de la glicinamida ribonucleótido formiltransferasa.